Scholars Central

ArticlePublished 30 Sep 2024

Emerging Trends in Autoimmune Rheumatic Diseases Treatment: A New Era of Personalized Medicine

Authors: Adaba Baoro

International Journal of Clinical Rheumatology

Volume 19 · Issue 9 · Pages 245–248

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Autoimmune rheumatic diseases (AIRD) represent a heterogeneous group of chronic, inflammatory disorders in which the body’s immune system mistakenly attacks its own tissues. Conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and scleroderma have traditionally been treated using broad-spectrum therapies with variable efficacy across individuals. However, recent advances in genomics, proteomics, and biomarker research are driving the development of personalized medicine, which tailors treatment to an individual’s genetic and molecular profile. This article explores the emerging trends in the treatment of AIRD, focusing on the shift towards precision medicine. It examines the impact of biological therapies, genetic testing, and the role of biomarkers in guiding treatment decisions. Additionally, the challenges of cost, accessibility, and global disparities in healthcare access are discussed. The future of autoimmune rheumatic disease management is inextricably linked to personalized approaches that ensure better outcomes for patients, but these must be coupled with efforts to make such treatments widely accessible.

Subjects

Rheumatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical Rheumatology
  • SubjectRheumatology
  • BylineArticles whose byline prints “Adaba Baoro”